Citadel Advisors - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.8%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$5,345,000
-12.2%
155,151
-57.4%
0.00%0.0%
Q2 2020$6,087,000
+0.4%
364,315
-13.4%
0.00%
-33.3%
Q1 2020$6,065,000
-57.7%
420,701
-1.8%
0.00%
-50.0%
Q4 2019$14,338,000
+31.9%
428,393
-17.5%
0.01%
+20.0%
Q3 2019$10,871,000
+35.5%
519,171
+34.7%
0.01%
+25.0%
Q2 2019$8,025,000
+59.9%
385,416
+71.6%
0.00%
+100.0%
Q1 2019$5,020,000
-24.7%
224,635
-19.4%
0.00%
-50.0%
Q4 2018$6,668,000
+311.4%
278,779
+369.2%
0.00%
Q3 2018$1,621,000
-24.5%
59,415
-25.6%
0.00%
-100.0%
Q2 2018$2,148,000
+157.9%
79,891
+205.3%
0.00%
Q1 2018$833,000
-4.8%
26,164
+13.1%
0.00%
-100.0%
Q4 2017$875,000
-93.7%
23,133
-95.9%
0.00%
-90.9%
Q3 2017$13,873,000
+3753.6%
559,641
+3092.5%
0.01%
Q2 2017$360,000
-49.5%
17,530
-49.7%
0.00%
-100.0%
Q4 2016$713,000
+180.7%
34,868
+105.8%
0.00%
Q3 2016$254,000
+36.6%
16,944
-1.6%
0.00%
Q2 2016$186,00017,2230.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders